Literature DB >> 25650236

Platelet-neutrophil interactions under thromboinflammatory conditions.

Jing Li1, Kyungho Kim, Andrew Barazia, Alan Tseng, Jaehyung Cho.   

Abstract

Platelets primarily mediate hemostasis and thrombosis, whereas leukocytes are responsible for immune responses. Since platelets interact with leukocytes at the site of vascular injury, thrombosis and vascular inflammation are closely intertwined and occur consecutively. Recent studies using real-time imaging technology demonstrated that platelet-neutrophil interactions on the activated endothelium are an important determinant of microvascular occlusion during thromboinflammatory disease in which inflammation is coupled to thrombosis. Although the major receptors and counter receptors have been identified, it remains poorly understood how heterotypic platelet-neutrophil interactions are regulated under disease conditions. This review discusses our current understanding of the regulatory mechanisms of platelet-neutrophil interactions in thromboinflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25650236      PMCID: PMC4480154          DOI: 10.1007/s00018-015-1845-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  218 in total

1.  Roles of phospholipase C beta2 in chemoattractant-elicited responses.

Authors:  H Jiang; Y Kuang; Y Wu; W Xie; M I Simon; D Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  An unexpected role for hypoxic response: oxygenation and inflammation.

Authors:  Carole Peyssonaux; Randall S Johnson
Journal:  Cell Cycle       Date:  2004-02       Impact factor: 4.534

3.  Src family kinases mediate neutrophil adhesion to adherent platelets.

Authors:  Virgilio Evangelista; Zehra Pamuklar; Antonio Piccoli; Stefano Manarini; Giuseppe Dell'elba; Romina Pecce; Nicola Martelli; Lorenzo Federico; Mauricio Rojas; Giorgio Berton; Clifford A Lowell; Licia Totani; Susan S Smyth
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

4.  NF-kappaB inhibitors impair platelet activation responses.

Authors:  E Malaver; M A Romaniuk; L P D'Atri; R G Pozner; S Negrotto; R Benzadón; M Schattner
Journal:  J Thromb Haemost       Date:  2009-06-03       Impact factor: 5.824

Review 5.  Structure and function of the glycoprotein Ib-IX-V complex.

Authors:  J A López; J F Dong
Journal:  Curr Opin Hematol       Date:  1997-09       Impact factor: 3.284

Review 6.  The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury.

Authors:  R R Thiagarajan; R K Winn; J M Harlan
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

7.  Inhibition of protein tyrosine phosphatases suppresses P-selectin exocytosis in activated human platelets.

Authors:  M Chen; J G Geng
Journal:  Biochem Biophys Res Commun       Date:  2001-08-31       Impact factor: 3.575

Review 8.  NADPH oxidases: functions and pathologies in the vasculature.

Authors:  Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

Review 9.  Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways.

Authors:  Krisztina Futosi; Szabina Fodor; Attila Mócsai
Journal:  Int Immunopharmacol       Date:  2013-11-18       Impact factor: 4.932

10.  Gene targeting implicates Cdc42 GTPase in GPVI and non-GPVI mediated platelet filopodia formation, secretion and aggregation.

Authors:  Huzoor Akbar; Xun Shang; Rehana Perveen; Mark Berryman; Kevin Funk; James F Johnson; Narendra N Tandon; Yi Zheng
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

View more
  29 in total

1.  Platelet Protein Disulfide Isomerase Promotes Glycoprotein Ibα-Mediated Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions.

Authors:  Jing Li; Kyungho Kim; Si-Yeon Jeong; Joyce Chiu; Bei Xiong; Pavel A Petukhov; Xiangrong Dai; Xiaoyi Li; Robert K Andrews; Xiaoping Du; Philip J Hogg; Jaehyung Cho
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

2.  Targeting AnxA1/Formyl Peptide Receptor 2 Pathway Affords Protection against Pathological Thrombo-Inflammation.

Authors:  Shantel A Vital; Elena Y Senchenkova; Junaid Ansari; Felicity N E Gavins
Journal:  Cells       Date:  2020-11-13       Impact factor: 6.600

3.  Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease.

Authors:  Jing Li; Si-Yeon Jeong; Bei Xiong; Alan Tseng; Andrew B Mahon; Steven Isaacman; Victor R Gordeuk; Jaehyung Cho
Journal:  Haematologica       Date:  2019-10-31       Impact factor: 9.941

4.  Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia.

Authors:  Sivasami Pulavendran; Jennifer M Rudd; Prasanthi Maram; Paul G Thomas; Ramachandran Akhilesh; Jerry R Malayer; Vincent T K Chow; Narasaraju Teluguakula
Journal:  Am J Respir Cell Mol Biol       Date:  2019-12       Impact factor: 6.914

Review 5.  Ser/Thr protein kinase Bβ-NADPH oxidase 2 signaling in thromboinflammation.

Authors:  Jing Li; Jaehyung Cho
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

6.  Neutrophils develop rapid proinflammatory response after engulfing Hb-activated platelets under intravascular hemolysis.

Authors:  A Bhasym; G K Annarapu; S Saha; N Shrimali; S Gupta; T Seth; P Guchhait
Journal:  Clin Exp Immunol       Date:  2019-05-27       Impact factor: 4.330

7.  NOX2 is critical for heterotypic neutrophil-platelet interactions during vascular inflammation.

Authors:  Kyungho Kim; Jing Li; Alan Tseng; Robert K Andrews; Jaehyung Cho
Journal:  Blood       Date:  2015-09-02       Impact factor: 22.113

8.  Hydroxyurea with AKT2 inhibition decreases vaso-occlusive events in sickle cell disease mice.

Authors:  Andrew Barazia; Jing Li; Kyungho Kim; Namrata Shabrani; Jaehyung Cho
Journal:  Blood       Date:  2015-08-11       Impact factor: 22.113

9.  ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease.

Authors:  Kyungho Kim; Jing Li; Andrew Barazia; Alan Tseng; Seock-Won Youn; Giovanni Abbadessa; Yi Yu; Brian Schwartz; Robert K Andrews; Victor R Gordeuk; Jaehyung Cho
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

Review 10.  ERO1-PDI Redox Signaling in Health and Disease.

Authors:  Vishwanath Jha; Tripti Kumari; Vijayprakash Manickam; Zahra Assar; Kirk L Olson; Jeong-Ki Min; Jaehyung Cho
Journal:  Antioxid Redox Signal       Date:  2021-07-13       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.